America's Choice Provider Network to Cover CombiMatrix's Molecular Dx Testing Services | GenomeWeb

NEW YORK (GenomeWeb News) – America's Choice Provider Network will now cover CombiMatrix's diagnostic laboratory services, CombiMatrix said today.

ACPN is a San Diego-based company that facilitates out-of-network services for more than 540 payers in the US, reaching about 14 million people. Under the new agreement, individuals whose healthcare providers liaise with ACPN will now have access to CombiMatrix's menu of chromosomal microarray-based prenatal, pediatric, and cancer cytogenetic testing services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.